Market Reports Online

Global Irritable Bowel Syndrome (IBS) Market 2017 Opportunities and Trends


Dallas, TX -- (ReleaseWire) -- 06/06/2014 -- The report titled ‘Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)' provides an in depth analysis of IBS market on a global level. The report presents the global market sizing of IBS and also predicts the future growth of the market. The report also analyzes the various sub segments of the market and the worldwide sales of drugs available for the specific segment. Besides presenting the competitive landscape, the report also assesses the growth of IBS market in United States, Japan, and the United Kingdom. It also includes the penetration rate of the disorder in Germany, France, Italy, Spain and Belgium. In addition, the report focuses on the various growth drivers and challenges faced by the Irritable Bowel Syndrome (IBS) market.

Purchase a copy of this report @

Geographical Coverage
1. United States
- Market Size
- Laxatives market growth projections
2. European Union
- Market Size
- Country wise Analysis
3. Japan
- Market Size
- Prevalence based on Subtype
Company Coverage
- Abbott Laboratories
- Lexicon Pharmaceuticals
- Ironwood
- Salix Pharmaceuticals
- Sucampo

Irritable Bowel Syndrome or IBS is a gastrointestinal disorder in which the colon muscle contracts more readily. The high prevalence of this syndrome could be estimated from the fact that 1 out of every 5 American is affected by the disorder and it is more common in women. Though the exact cause of the disorder is still unknown, factors like food, medicine, lifestyle and emotional stress can trigger the condition.

Complete report available @

The global IBS market holds immense business opportunities as there are very few drugs and treatment available in the market. Moreover, only about 60% of the patient suffering from the syndrome tends to seek medical aid. The market is characterized with high unmet demand for proper treatment and this has resulted in many ongoing research and clinical trials. At present Amitiza and Lotronex are the only FDA approved drugs available in the market, which has created a necessity for more drugs and therapies in the Irritable Bowel Syndrome market. The IBS market is likely to witness arrival of many other drugs and first class therapies in the foreseeable future leading to generic competition in the market.

Major points from Table of Contents ( ) are listed below:

1. Executive Summary
2. Global Irritable Bowel Syndrome (IBS) Market: An Analysis
3. Global Irritable Bowel Syndrome (IBS) Market: Geographical Analysis
4. Porter's Five Forces Analysis
5. Growth Drivers
6. Challenges
7. Company Analysis
8. about Us
List of Figures
List of Tables

Related Reports on Pharmaceuticals Market:

Global Vitamin and Provitamin Market to 2018 - Market Size, Trends, and Forecasts @

Deals in Oncology Personalized Medicine Industry - Worldwide Analysis @

Contact for further information/ details.